Johnson & Johnson’s COVID-19 candidate enters third trial phase

The company will become the first to test the simpler regimen of its candidate which is being developed by Janssen Pharmaceutical Companies, Dr. Dan Barouch, director of the Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center, told FOX Business. Read Article